A world-class platform of radiopharmaceutical and nuclear medicine products for both diagnostic and therapeutic uses.
Radiopharm Theranostics is at the forefront of biotechnology research, dedicated to developing a world-class platform of radiopharmaceutical and nuclear medicine products. With a focus on both diagnostic and therapeutic applications, Radiopharm Theranostics is committed to innovation in the healthcare sector. The company operates primarily out of its Sydney, AU headquarters.
Radiopharm Theranostics specializes in a range of critical areas, including drug discovery, monoclonal antibodies, and cancer research. By targeting diseases such as lung cancer, breast cancer, pancreatic cancer, and brain cancer, Radiopharm Theranostics aims to significantly improve patient outcomes through advanced therapeutic and diagnostic solutions. Radiopharm Theranostics's commitment to clinical trials and cutting-edge technology positions it as a key player in the advancement of nuclear medicine.
Radiopharm Theranostics is poised for continued growth and success in the biotechnology industry. As Radiopharm Theranostics continues to expand its capabilities and portfolio, it remains dedicated to providing innovative solutions that address critical healthcare needs. We invite the management of Radiopharm Theranostics to create a customized and exclusive company showcase and product listing on our platform to further enhance their market presence.
Compare Radiopharm Theranostics with 3 companies in Biotechnology-Research
| Comparison Field |
Radiopharm TheranosticsMain Company |
Flagship PioneeringView Profile |
ClearView Healthcare...View Profile |
LUKA GLOBALView Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2000 | 2007 | 2019 |
|
Company Size
|
— | 201-500 | 201-500 | 2-10 |
|
City
|
Cambridge, MA | Newton, MA | ||
|
Country
|
United States | United States | ||
|
Skills & Keywords
Comparing with main company
|
34 Total Skills
Radiopharmaceuticals
Nuclear Medicine
Theranostics
Biotechnology
Cancer Research
Drug Discovery
Clinical Trials
patients
drugdiscovery
monoclonalantibodies
lungcancer
cancerresearch
biotech
breastcancerimaging
nuclearmedicine
medtech
therapeutics
breastcancer
therapeutic
neckcancer
cancer
diagnostics
radiopharmaceuticals
biotechnology
clinicaltrials
health
radioactivedrugs
pancreaticcancer
braincancer
glioblastoma
peptides
smallmolecules
antibodies
HER2
|
12 Total
12 Unique
Unique Skills:
agtech
artificial intelligence
biology
climate change
entrepreneurship
innovation
+6
|
16 Total
16 Unique
Unique Skills:
advanced analytics
analyst
analytics
consultant
consulting
healthcare
+10
|
29 Total
29 Unique
Unique Skills:
aerospace
agritech
cleantech
coaching
consulting
contracting
+23
|
Other organizations in the same industry
This company is also known as